BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37729705)

  • 21. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoprotection against influenza virus H9N2 by the oral administration of recombinant Lactobacillus plantarumNC8 expressing hemagglutinin in BALB/c mice.
    Shi SH; Yang WT; Yang GL; Cong YL; Huang HB; Wang Q; Cai RP; Ye LP; Hu JT; Zhou JY; Wang CF; Li Y
    Virology; 2014 Sep; 464-465():166-176. PubMed ID: 25083619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly(D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens.
    Singh SM; Alkie TN; Nagy É; Kulkarni RR; Hodgins DC; Sharif S
    Vaccine; 2016 Sep; 34(40):4807-13. PubMed ID: 27543454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant Lactobacillus plantarum expressing HA2 antigen elicits protective immunity against H9N2 avian influenza virus in chickens.
    Yang WT; Yang GL; Yang X; Shonyela SM; Zhao L; Jiang YL; Huang HB; Shi CW; Wang JZ; Wang G; Zhao JH; Wang CF
    Appl Microbiol Biotechnol; 2017 Dec; 101(23-24):8475-8484. PubMed ID: 29090342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.
    Choi EH; Song MS; Park SJ; Pascua PN; Baek YH; Kwon HI; Kim EH; Kim S; Jang HK; Poo H; Kim CJ; Choi YK
    Arch Virol; 2015 Jul; 160(7):1729-40. PubMed ID: 25959557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trend of Changes in the Titer of Antibody against Avian Influenza Virus H9n2 during Raising Period in Vaccinated and Unvaccinated Broiler Farms in Qazvin Province, Iran: A Cohort Study.
    Mirzaiee K; Shoushtari A; Bokaie S; Fallah Mehrabadi MH; Peighambari SM
    Arch Razi Inst; 2020 Mar; 75(1):9-16. PubMed ID: 32291997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotypic evolution and epidemiological characteristics of H9N2 influenza virus in Shandong Province, China.
    Li Y; Liu M; Sun Q; Zhang H; Zhang H; Jiang S; Liu S; Huang Y
    Poult Sci; 2019 Sep; 98(9):3488-3495. PubMed ID: 30941436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.
    Kandeil A; Moatasim Y; Gomaa MR; Shehata MM; El-Shesheny R; Barakat A; Webby RJ; Ali MA; Kayali G
    Vaccine; 2016 Jan; 34(2):218-224. PubMed ID: 26620838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low pathogenic avian influenza (H9N2) in chicken: Evaluation of an ancestral H9-MVA vaccine.
    Ducatez MF; Becker J; Freudenstein A; Delverdier M; Delpont M; Sutter G; Guérin JL; Volz A
    Vet Microbiol; 2016 Jun; 189():59-67. PubMed ID: 27259828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial heterologous protection by low pathogenic H9N2 virus against natural H9N2-PB1 gene reassortant highly pathogenic H5N1 virus in chickens.
    Dash SK; Kumar M; Kataria JM; Nagarajan S; Tosh C; Murugkar HV; Kulkarni DD
    Microb Pathog; 2016 Jun; 95():157-165. PubMed ID: 27057675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Combination of Recombinant HA1-and Nucleoprotein-Based Chitosan Nanoparticles Induces Early and Potent Immune Responses Against the H9N2 Influenza Virus.
    Shahsavandi S; Ebrahimi MM; Fotouhi F; Tebianian M
    Viral Immunol; 2022 Jun; 35(5):365-374. PubMed ID: 35527642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Dose-Response Study of Inactivated Low Pathogenic Avian Influenza H9N2 Virus in Specific-Pathogen-Free and Commercial Broiler Chickens.
    Kilany WH; Ali A; Bazid AH; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
    Avian Dis; 2016 May; 60(1 Suppl):256-61. PubMed ID: 27309065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intranasally administered polyethylenimine adjuvanted influenza M2 ectodomain induces partial protection against H9N2 influenza A virus infection in chickens.
    Hajam IA; Kim J; Lee JH
    Vet Immunol Immunopathol; 2019 Mar; 209():78-83. PubMed ID: 30885310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quick and improved immune responses to inactivated H9N2 avian influenza vaccine by purified active fraction of Albizia julibrissin saponins.
    Sun H; Fei L; Zhu B; Shi M
    BMC Vet Res; 2020 Nov; 16(1):427. PubMed ID: 33160337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid production of a H₉ N₂ influenza vaccine from MDCK cells for protecting chicken against influenza virus infection.
    Ren Z; Lu Z; Wang L; Huo Z; Cui J; Zheng T; Dai Q; Chen C; Qin M; Chen M; Yang R
    Appl Microbiol Biotechnol; 2015 Apr; 99(7):2999-3013. PubMed ID: 25646963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bursopentine as a novel immunoadjuvant enhances both humoral and cell-mediated immune responses to inactivated H9N2 Avian Influenza virus in chickens.
    Li D; Xue M; Wang C; Wang J; Chen P
    Clin Vaccine Immunol; 2011 Sep; 18(9):1497-502. PubMed ID: 21795462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immune system of chicken and its response to H9N2 avian influenza virus.
    Yang W; Liu X; Wang X
    Vet Q; 2023 Dec; 43(1):1-14. PubMed ID: 37357919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative immune response and pathogenicity of the H9N2 avian influenza virus after administration of Immulant
    Eladl AH; Arafat N; El-Shafei RA; Farag VM; Saleh RM; Awadin WF
    Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():165-175. PubMed ID: 31300109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carboxymethyl chitosan bounded iron oxide nanoparticles and gamma-irradiated avian influenza subtype H9N2 vaccine to development of immunity on mouse and chicken.
    Motamedi-Sedeh F; Saboorizadeh A; Khalili I; Sharbatdaran M; Wijewardana V; Arbabi A
    Vet Med Sci; 2022 Mar; 8(2):626-634. PubMed ID: 34878724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-infection of
    Arafat N; Abd El Rahman S; Naguib D; El-Shafei RA; Abdo W; Eladl AH
    Avian Pathol; 2020 Oct; 49(5):496-506. PubMed ID: 32835500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.